On November 2, 2023 Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, reported that management will participate in five upcoming investor conferences (Press release, Arvinas, NOV 2, 2023, View Source [SID1234636732]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Truist Securities BioPharma Symposium on Wednesday, November 8.
Sean Cassidy, chief financial officer, and Ron Peck, M.D., chief medical officer will be available to participate in one-on-one meetings.
Stifel Healthcare Conference on Tuesday, November 14.
John Houston, Ph.D., chairperson, chief executive officer, and president, and Ron Peck, M.D., chief medical officer, will be available to participate in one-on-one meetings and will participate in a fireside chat. A live audio webcast of the presentation will be on the Events + Presentations section of the Company’s website.
Jefferies London Healthcare Conference on Thursday, November 16.
John Houston, Ph.D., chairperson, chief executive officer, and president, and Sean Cassidy, chief financial officer will be available to participate in one-on-one meetings.
Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28.
Ian Taylor, Ph.D., chief scientific officer, and Randy Teel, Ph.D., senior vice president, corporate and business development, will be available to participate in one-on-one meetings and will participate in a fireside chat. A live audio webcast of the presentation will be on the Events + Presentations section of the Company’s website.
6th Annual Evercore ISI HealthCONx Conference on Thursday, November 30.
Ron Peck, M.D., chief medical officer and Jeff Boyle, vice president, investor relations, will be available to participate in one-on-one meetings and will participate in a fireside chat. A live audio webcast of the presentation will be on the Events + Presentations section of the Company’s website.